Report #2840695

Received May 13, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 59 yrs
State: VT
Recovered: Recovered
Vaccinated: Apr 30, 2025
Onset: Apr 30, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	2	945660	LA

Symptoms (2)

Injection site painNausea

Symptom narrative

Patient reported nausea for 24 hours following immunization, soreness at injection site.

Current illness

None reported

Medical history

Asthma, HLD, HTN, chronic allergic rhinitis, endometrial hyperplasia, urge incontinence of urine, benign neoplasm of adrenal gland, DM Type II, Obesity, GERD, mixed IBS, Vit D Deficiency, anxiety, depression, back pain, restless legs, OSA

Other medications

Tirzepatide, meloxicam, tizanidine, gabapentin, prazosin, pantoprazole, trazodone, atorvastatin, hydroxyzine, fexofenadine, famotidine, metformin, citalopram, losartan, bupropion, symbicort, multivitamin, vitamin D

Allergies

PCN, atenolol, lisinopril

Lab data

n/a